Girard Partners LTD. raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.2% during the 3rd quarter, Holdings Channel reports. The fund owned 21,756 shares of the medical research company’s stock after purchasing an additional 1,076 shares during the period. Girard Partners LTD.’s holdings in Charles River Laboratories […]
Advisor OS LLC boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 66.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,538 shares of the medical research company’s stock after purchasing an additional 5,794 […]
Congress Wealth Management LLC DE increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 53,514 shares of the medical research company’s stock after buying an […]
Eads & Heald Wealth Management increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 20.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,175 shares of the medical research company’s stock after acquiring an additional 547 shares […]
Eads & Heald Wealth Management increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 20.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 3,175 shares of the medical research company’s stock after acquiring an additional 547 shares during the quarter. Eads & Heald Wealth Management’s holdings in Charles […]